Efficacy and safety of paediatric medicinal cannabis use: A scoping review
Please use this link to access this publication.
Abstract
Introduction
The use of medicinal cannabis in the paediatric age group is increasing despite the lack of evidence for its efficacy or safety.
Objective
To map the available evidence on the efficacy and safety of medicinal cannabis in children and adolescents.
Methods
We conducted a scoping review and searched six electronic databases and grey literature. A study was eligible for inclusion when it investigated the efficacy or safety of medicinal cannabis for any condition, more than half of the participants were 0 to 18 years old, and had any study design except single case reports.
Results
We included 36 studies in our final analysis, 32 of which investigated the efficacy or safety of cannabis in treatment-resistant epilepsy. The remaining 4 studies examined patients with cancer, dysautonomia, Epidermolysis Bullosa, and motor disorders.
Conclusions
There is a lack of evidence on the efficacy and safety of medicinal cannabis in most paediatric conditions.
This library aims to empower you with knowledge but it does not replace the personalized advice and guidance a healthcare professional can provide. Before implementing any changes to your health regimen based on the contents of this library, we strongly advise you to consult with a qualified healthcare professional. Your doctor’s expertise is essential for interpreting how these insights may apply to your unique health circumstances.